bioMérieux SA (BMXMF)
bioMérieux Market Cap: 14.32B for Jan. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| DBV Technologies SA | 593.75M |
| Cellectis SA | 405.31M |
| Innate Pharma SA | 165.86M |
| Inventiva SA | 956.84M |
| Nanobiotix SA | 977.20M |
Market Cap Related Metrics
| PS Ratio | 3.219 |
| PEG Ratio | 19.22 |
| Price to Free Cash Flow | 30.23 |
| Price | 121.32 |
| Earnings Yield | 2.85% |
| PEGY Ratio | 13.15 |
| Operating PE Ratio | 21.03 |
| Normalized PE Ratio | 27.44 |